Skip to main navigationSkip to main content
The University of Southampton
Health Sciences

Health Sciences’ academic receives Queen’s Birthday Honours

Published: 13 June 2016
Dr Alan Borthwick, OBE
Dr Alan Borthwick, OBE

Dr Alan Borthwick, Associate Professor in the Centre for Innovation and Leadership, has received an OBE for services to health and health research in the Queen’s Birthday Honours.

Dr Alan Borthwick said: “For me it is a very great honour to be the recipient of an OBE, which I view as an acknowledgement of the work by my colleagues here in Southampton and of the College of Podiatry and which highlights the very significant contribution to healthcare made by podiatrists.”

Alan is one of two leading academics from the University of Southampton to receive an award. Professor Peter Johnson, Cancer Research UK Chair of Medical Oncology, has also received a CBE in recognition for his services to medicine and higher education.

Professor Sir Christopher Snowden, University of Southampton President and Vice-Chancellor, said: “I am delighted that the exceptional contributions of Peter and Alan have been recognised. Peter’s leadership in oncology and immunotherapy have been of fundamental importance both nationally and at the University of Southampton. Alan has been the driving force behind important developments in the healthcare profession and podiatry.”

Dr Borthwick, a podiatrist by background, represented the Allied Health Professions Federation on the Department of Health Project Board in securing independent prescribing rights for the professions of podiatry and physiotherapy, and also contributed to changes in legislation enabling additions to the statutory exemptions available to podiatrists. He has been a member of the medicines committee of the College of Podiatry for 15 years, and was its chairman for seven years.

Professor Johnson leads the Southampton Cancer Research UK Centre and is Chief Clinician for Cancer Research UK. Professor Johnson is a medical oncologist specialising in the treatment of lymphoma. He has led lymphoma clinical trials from large international studies involving hundreds of patients from around the world, to first-in-man trials of new antibody treatments developed by laboratories in Southampton and elsewhere.

Professor Johnson’s main research interest is in immunotherapy - using the immune system to fight cancer – and he has been instrumental in the University’s fundraising campaign to open a Centre for Cancer Immunology in 2017, the first of its kind in the UK.

Related Staff Member

Privacy Settings